Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Mar 1;40(7):693-697.
doi: 10.1200/JCO.21.02550. Epub 2022 Jan 24.

Human Epidermal Growth Factor Receptor 2-Mutant Non-Small-Cell Lung Cancer: Continued Progress But Challenges Remain

Alissa J Cooper  1 , Justin F Gainor  1
Affiliations
Editorial

Human Epidermal Growth Factor Receptor 2-Mutant Non-Small-Cell Lung Cancer: Continued Progress But Challenges Remain

Alissa J Cooper et al. J Clin Oncol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Justin F. GainorThis author is a member of the Journal of Clinical Oncology Editorial Board. Journal policy recused the author from having any role in the peer review of this manuscript.Employment: Ironwood Pharmaceuticals (I)Stock and Other Ownership Interests: Ironwood Pharmaceuticals (I)Honoraria: Merck, Incyte, ARIAD, Novartis, Pfizer, TakedaConsulting or Advisory Role: Genentech, Bristol Myers Squibb, Theravance, Loxo, Takeda, Array BioPharma, Amgen, Merck, Agios, Regeneron, Oncorus, Jounce Therapeutics, Blueprint Medicines, Gilead Sciences, Lilly, Moderna Therapeutics, Karyopharm, AstraZenecaResearch Funding: Merck (Inst), Novartis (Inst), Genentech, Bristol Myers Squibb (Inst), Adaptimmune (Inst), AstraZeneca (Inst), ARIAD, Jounce Therapeutics (Inst), Blueprint Medicines (Inst), Moderna Therapeutics (Inst), Tesaro (Inst), Alexo Therapeutics (Inst), Array BioPharma (Inst)Open Payments Link: https://openpaymentsdata.cms.gov/physician/775917No other potential conflicts of interest were reported.

Comment on

MeSH terms